JT
ACAD icon

Jump Trading’s Acadia Pharmaceuticals ACAD Stock Holding History

Jump Trading’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-266
Closed -$744K – 643
2016
Q1 		$744K Buy
+266
New +$5.8K 0.03% 255
2015
Q2 		– Sell
-26,700
Closed -$870K – 1084
2015
Q1 		$870K Buy
+26,700
New +$918K 0.03% 279
2014
Q4 		– Sell
-900
Closed -$22K – 951
2014
Q3 		$22K Buy
+900
New +$21K ﹤0.01% 996

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jump Trading's ACAD Position: Q4 2014 in Review

Jump Trading sold out of Acadia Pharmaceuticals (ACAD) in Q4 2014, closing a stake of 1,068 shares — an estimated $26K sold.

Jump Trading first reported a position in ACAD in Q3 2014 and held it in 1 quarter. The position peaked at $26K in Q3 2014. 182 funds tracked by Wall St. Rank hold ACAD as of Q4 2014.

  • Jump Trading reported no remaining Acadia Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Jump Trading sold 1,068 Acadia Pharmaceuticals shares in Q4 2014, an estimated $26K.
  • Jump Trading first reported a position in Acadia Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • Jump Trading's Acadia Pharmaceuticals position peaked at $26K in Q3 2014.
  • 182 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2014.

Based on Jump Trading's 13F filing for Q4 2014, filed 17 Feb 2015.